TAGCyx Biotechnologies Inc.
PrivateLast Round
Grant
Apr 16, 2026
Total Funding Raised
$13.31M
Company Overview
TAGCyx Biotechnologies Inc. is a biotechnology company that develops oligonucleotide aptamer-based pharmaceuticals and medical devices using its proprietary Xenoligo® drug discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TAGCyx Biotechnologies Inc. Comparables
Compare TAGCyx Biotechnologies Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Guardian Therapeutics | 81% | |
| Aptagen, LLC | 79% | |
| NeoVentures Biotechnology Inc. | 78% | |
TAGCyx Biotechnologies Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 16, 2026 | ||||
| Series C Extension | Jul 7, 2021 | ||||
| Series C | May 18, 2020 | ||||
| Series B | Apr 27, 2018 | ||||
| Series A | Aug 31, 2016 |
TAGCyx Biotechnologies Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Japan Agency for Medical Research and Development | Grant |
| Mizuho Capital | Series B |
| UTEC (The University of Tokyo Edge Capital Partners) | Series B, Series A |
| Nissay Capital | Series A |
| 株式会社ヘルスケア・イノベーション | Series C Extension |
| SBI Holdings | Series C Extension |
| SMBC Venture Capital | Series B, Series A |
TAGCyx Biotechnologies Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TAGCyx Biotechnologies Inc.'s valuation, stock price, and market status.